Skip directly to site content Skip directly to page options Skip directly to A-Z link Skip directly to A-Z link Skip directly to A-Z link
Volume 25, Number 4—April 2019

Mucosal Leishmaniasis in Travelers with Leishmania braziliensis Complex Returning to Israel

Michal Solomon, Nadav Sahar, Felix Pavlotzky, Aviv Barzilai, Charles L. Jaffe, Abedelmajeed Nasereddin, and Eli SchwartzComments to Author 
Author affiliations: Sheba Medical Center, Tel Aviv, Israel (M. Solomon, N. Sahar, F. Pavlotzky, A. Barzilai, E. Schwartz); Hebrew University–Hadassah Medical School, Jerusalem, Israel (C.L. Jaffe, A. Nasereddin)

Main Article

Table 1

Comparison between patients with New World CL and those with ML, Israel, 1993–2015*

No. patients 128 17
Sex ratio, M:F 105:23 (82% male) 16:1 (94% male)
Mean age, y 24.2 27.6
Infected in Bolivia 83/100 (83%) 17/17(100%)
No. lesions 1.8 2.3
>3 lesions 21/128 (16%) 5/17 (29%)
Lesion above waist 61/81 (75%) 9/17 (53%)
PCR positive 68/76 (89%) 15/17 (88%)

*Differences between categories were not significant. CL, cutaneous leishmaniasis; ML, mucosal leishmaniasis.

Main Article

Page created: March 17, 2019
Page updated: March 17, 2019
Page reviewed: March 17, 2019
The conclusions, findings, and opinions expressed by authors contributing to this journal do not necessarily reflect the official position of the U.S. Department of Health and Human Services, the Public Health Service, the Centers for Disease Control and Prevention, or the authors' affiliated institutions. Use of trade names is for identification only and does not imply endorsement by any of the groups named above.